CytoSorbents Corp. (CTSO)
0.741
-0.01
(-1.53%)
USD |
NASDAQ |
Mar 02, 10:34
CytoSorbents EPS Diluted (Quarterly) : -0.0505 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Delcath Systems, Inc. | -0.052 |
| Quest Diagnostics, Inc. | 2.188 |
| Danaher Corp. | 1.684 |
| Cardiac Biotech Solutions, Inc. | -0.0035 |
| Odyssey Health, Inc. | -0.0046 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -3.17M |
| Revenue (Quarterly) | 9.485M |
| Total Expenses (Quarterly) | 12.66M |
| Enterprise Value | 67.14M |
| Gross Profit Margin (Quarterly) | 70.28% |
| Profit Margin (Quarterly) | -33.42% |
| Earnings Yield | -25.63% |
| Normalized Earnings Yield | -25.30 |